Trade Carl Zeiss Meditec AG - AFX CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.12
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment€1,000.00Overnight funding adjustmentCharges from full value of position-0.017318 %(-€3.46)Trade size with leverage ~ €20,000.00Money from leverage ~ $€19,000.00Go to platform: -0.01732%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment€1,000.00Overnight funding adjustmentCharges from full value of position-0.004904 %(-€0.98)Trade size with leverage ~ €20,000.00Money from leverage ~ $€19,000.00Go to platform: -0.00490%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: EUR
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: Germany
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: €1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.017318 %
  (-€3.46)

• Margin. Your investment: €1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.004904 %
  (-€0.98)

Key Stats

• Prev. Close: 31.04
• Open: 31.42
• 1-Year Change: -24.34%
• Day's Range: 31.42 - 31.96

Trade Carl Zeiss Meditec AG - AFX

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.

Financial summary

BRIEF: For the three months ended 31 December 2021, Carl Zeiss Meditec AG revenues increased 11% to EUR410.2M. Net income decreased 18% to EUR37.9M. Revenues reflect Ophthalmic Devices segment increase of 10% to EUR310.9M, Microsurgery segment increase of 16% to EUR99.3M, Asia/Pacific Region segment increase of 15% to EUR181.5M, EMEA segment increase of 5% to EUR114.1M.

Equity composition

10/2006, Rights Issue, 3 new shares for every 2 shares held @ EUR 10.1 (Factor: 1.369066).